Search results
Found 2808 matches for
Researchers from the University of Oxford have published further data from the Phase I/II clinical trials of the ChAdOx1 nCoV-19 coronavirus vaccine, evidencing the decision to move to a two-dose regimen in ongoing phase III trials, and how ChAdOx1 nCov-19 induces broad antibody and T cell functions.
OVG Alumni
Browse the OVG Alumni, including those who have undertaken a PhD/DPhil, MSc or MD (a graduate degree in the UK for medical graduates) at OVG since 2001, with date of graduation and where available information on their current or most recent/notable role.